Clinical Guidance and Pathways
On this page you will find clinical guidance and treatment pathways that have been approved by the Humber and North Yorkshire Integrated Medicines Optimisation Committee (HNY IMOC).
Diabetes
- Humber and North Yorkshire Type 2 Diabetes Algorithm
- Humber and North Yorkshire Blood Glucose Meter Formulary
- Humber and North Yorkshire Continuous Glucose Monitoring Policy
- Medicine Management Enhanced Service Scheme 2023/2024 – Diabetes Implementation guidance and advice
Respiratory
- Humber and North Yorkshire Adult Asthma Guideline 2023
- Humber and North Yorkshire Children and Young People 12-17 years Asthma Guideline 2023
- Humber and North Yorkshire Children and Young People 6-11 years Asthma Guideline 2023
- Medicine Management Enhanced Service Scheme 2023/2024 – Asthma Implementation guidance and advice
Palliative Care
- A Guide to Symptom Management in Palliative Care
- Obtaining urgently required end of life medicines – guidance for North Yorkshire and York places July 2024
Community Pharmacy Clinical Protocols
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinders Stakeholder Briefing
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinders Extended Minor Illness Clinical Protocol
- Humber and North Yorkshire Community Pharmacy Hypertension Case Finding Escalation Protocol
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinders Hypertension Clinical Protocol
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinder CVD Primary Prevention Lipids Therapy
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinder SQuaDROM Addressing Polypharmacy Protocol
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinder SQuaDROM Unavailable Medicines Protocol
Ophthalmology